During the past decade, The New York Center for Travel and Tropical Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The New York Center for Travel and Tropical Medicine" are "COVID-19" (2 trials), "Gastrointestinal Disease" (1 trials), "Gastrointestinal Infection" (1 trials), "Health Care Worker" (1 trials) and "Hydroxychloroquine" (1 trials). Many other conditions were trialed in "The New York Center for Travel and Tropical Medicine" in a lesser frequency.

Most popular intervention types in "The New York Center for Travel and Tropical Medicine" are "Drug" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "AEMCOLO (Rifamycin SV MMX)" (1 trials), "Hydroxychloroquine Pre-Exposure Prophylaxis" (1 trials), "Nitazoxanide" (1 trials), "Placebo" (1 trials) and "Placebo oral tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "The New York Center for Travel and Tropical Medicine" are 3 trials for "All" genders.

Currently, there are NaN active trials in "The New York Center for Travel and Tropical Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in The New York Center for Travel and Tropical Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The New York Center for Travel and Tropical Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".